Evidence map›Paper›PMID 39011128›Full record

ArticleHemaSphere2024

CD49d expression is included in a revised 4-factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real-world experience.

Riccardo Bomben, Antonella Zucchetto, Roberta Laureana, Annalisa Chiarenza, Jacopo Olivieri, Erika Tissino, Francesca M Rossi, Filippo Vit, Tamara Bittolo, Robel Papotti and 30 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in HemaSphere, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

40 authors.

Riccardo BombenClinical and Experimental Onco-Haematology Unit Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Aviano Italy.
Antonella ZucchettoClinical and Experimental Onco-Haematology Unit Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Aviano Italy.
Roberta LaureanaDivision of Haematology University of Tor Vergata Rome Italy.
Annalisa ChiarenzaDivision of Hematology, Policlinico, Department of Surgery and Medical Specialties University of Catania Catania Italy.
Jacopo OlivieriClinica Ematologica, Centro Trapianti e Terapie Cellulari "Carlo Melzi" DISM Azienda Ospedaliera Universitaria S. Maria Misericordia Udine Italy.
Erika TissinoClinical and Experimental Onco-Haematology Unit Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Aviano Italy.
Francesca M RossiClinical and Experimental Onco-Haematology Unit Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Aviano Italy.
Filippo VitClinical and Experimental Onco-Haematology Unit Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Aviano Italy.
Tamara BittoloClinical and Experimental Onco-Haematology Unit Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Aviano Italy.
Robel PapottiClinical and Experimental Onco-Haematology Unit Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Aviano Italy.
Federico PozzoClinical and Experimental Onco-Haematology Unit Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Aviano Italy.
Annalisa GaglioClinical and Experimental Onco-Haematology Unit Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Aviano Italy.
Massimo DeganClinical and Experimental Onco-Haematology Unit Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Aviano Italy.
Jerry PoleselUnit of Cancer Epidemiology Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Aviano Italy.
Roberto MarascaHematology Unit, Department of Oncology and Hematology Azienda-Ospedaliero Universitaria (AOU) of Modena, Policlinico Modena Italy.
Andrea VisentinHematology unit, Department of Medicine University of Padova Padova Italy.
Riccardo MoiaDivision of Hematology, Department of Translational Medicine Università del Piemonte Orientale Novara Italy.
Idanna InnocentiFondazione Universitaria Policlinico A Gemelli di Roma Roma Italy.
Candida VitaleA.O.U. Città della Salute e della Scienza di Torino Torino Italy.
Roberta MurruHematology and Stem Cell Transplantation Unit, Ospedale A. Businco, ARNAS G. Brotzu Cagliari Italy.
Marzia VarettoniDivision of Hematology Fondazione IRCCS Policlinico San Matteo Pavia Italy.
Agostino TafuriDepartment of Clinical and Molecular Medicine and Hematology, Sant'Andrea - University Hospital - Sapienza University of Rome Rome Italy.
Francesco ZajaDepartment of Medical, Surgical and Health Sciences University of Trieste Trieste Italy.
Massimiliano PostorinoDivision of Haematology University of Tor Vergata Rome Italy.
Enrica A MartinoHematology Unit Azienda Ospedaliera Annunziata Cosenza Italy.
Adalgisa CondoluciOncology Institute of Southern Switzerland and Institute of Oncology Research Bellinzona Switzerland.
Davide RossiOncology Institute of Southern Switzerland and Institute of Oncology Research Bellinzona Switzerland.
Antonio CuneoHematology Section, Department of Medical Sciences University of Ferrara Ferrara Italy.
Francesco Di RaimondoDivision of Hematology, Policlinico, Department of Surgery and Medical Specialties University of Catania Catania Italy.
Paolo SportolettiCentro di Ricerca Emato-Oncologica (CREO), Dipartimento di Medicina e Chirurgia Università di Perugia Perugia Italy.
Ilaria Del GiudiceHematology, Department of Translational and Precision Medicine 'Sapienza' University Rome Italy.
Robin FoàHematology, Department of Translational and Precision Medicine 'Sapienza' University Rome Italy.
Francesca R MauroHematology, Department of Translational and Precision Medicine 'Sapienza' University Rome Italy.
Marta CosciaA.O.U. Città della Salute e della Scienza di Torino Torino Italy.
Luca LaurentiFondazione Universitaria Policlinico A Gemelli di Roma Roma Italy.
Gianluca GaidanoDivision of Hematology, Department of Translational Medicine Università del Piemonte Orientale Novara Italy.
Livio TrentinHematology unit, Department of Medicine University of Padova Padova Italy.
Maria I Del PrincipeDivision of Haematology University of Tor Vergata Rome Italy.
Massimo GentileHematology Unit Azienda Ospedaliera Annunziata Cosenza Italy.
Valter GatteiClinical and Experimental Onco-Haematology Unit Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Aviano Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39011128
PMCPMC11247362

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.